Naringenin solubilizing and pH dependent releasing properties of water soluble p-sulphonatocalix[4]arene

References

• Sangpheak W, Kicuntod J, Schuster R, et al. Physical properties and biological activities of hesperetin and naringenin in complex with methylated β-cyclodextrin. Beils J Org Chem. 2015;11(1):2763–2773.
   PubMedGoogle Scholar
• Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of u.s. adults. The J. of Nutr. 2007: 1244–1252.
   Google Scholar
• Bilia AR, Isacchi B, Righeschi C, et al. Flavonoids loaded in nanocarriers: an opportunity to increase oral bioavailability and bioefficacy. Food Nutr Sci. 2014;5(13):1212–1327.
   Google Scholar
• Sultana F, Rasool M. A novel therapeutic approach targeting rheumatoid arthritis by combined administration of morin, a dietary flavanol and non-steroidal anti-inflammatory drug indomethacin with reference to pro-inflammatory cytokines, inflammatory enzymes, RANKL and transcription factors. Chem Biolog Inter. 2015;230:58–70.
   PubMed Web of Science ®Google Scholar
• Ji P, Yu T, Liu Y, et al. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Dev Ther. 2016;10:911–925.
   PubMed Web of Science ®Google Scholar
• Krishnakumar N, Sulfikkarali N, Rajendra PN, et al. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Preven Nut. 2011;1(4):223–231.
   Google Scholar
• Kanno SI, Tomizawa A, Hiura T, et al. Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Bio Pharm Bull. 2005;28(3):527–530.
   PubMed Web of Science ®Google Scholar
• Xue Y, Guan Y, Zheng A, et al. Amphoteric calix [8] arene-based complex for pH-triggered drug delivery. Colloids Surf B. 2013;101:55–60.
   PubMed Web of Science ®Google Scholar
• Wang K, Guo DS, Wang X, et al. Multistimuli responsive supramolecular vesicles based on the recognition of p-sulfonatocalixarene and its controllable release of doxorubicin. ACS nano. 2011;5(4):2880–2894.
   PubMed Web of Science ®Google Scholar
• Shinde AJ. Solubilization of poorly soluble drugs: a review. Pharmainfo Net. 2007;5(6):36–44.
   Google Scholar
• Li H, Tan LL, Jia P, et al. Near-infrared light-responsive supramolecular nanovalve based on mesoporous silica-coated gold nanorods. Chem Sci. 2014;5(7):2804–2808.
   Web of Science ®Google Scholar
• Coll C, Bernardos A, Martínez-Máñez R. Gated silica mesoporous supports for controlled release and signaling applications. Acc Chem Res. 2012;46(2):339–349.
   PubMed Web of Science ®Google Scholar
• Yang YW. Towards biocompatible nanovalves based on mesoporous silica nanoparticles. Med Chem Comm. 2011;2(11):1033–1049.
   Web of Science ®Google Scholar
• Guo DS, Wang K, Wang YX. Cholinesterase-responsive supramolecular vesicle. J Am Chem Soc. 2012;134(24):10244–10250.
   PubMed Web of Science ®Google Scholar
• Sun YL, Yang BJ, Zhang SXA, et al. Cucurbit [7] uril Pseudorotaxane‐based photoresponsive supramolecular nanovalve. Chem-A Eur J. 2012;18(30):9212–9216.
   PubMed Web of Science ®Google Scholar
• Gallego-Yerga L, Lomazzi M, Sansone F, et al. Glycoligand-targeted core–shell nanospheres with tunable drug release profiles from calixarene–cyclodextrin heterodimers. Chem Comm. 2014;50(56):7440–7443.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmaco. 2010;62(11):1607–1621.
   Google Scholar
• Stancanelli R, Ficarra R, Cannavà C, et al. UV–vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-β-cyclodextrin inclusion complex. J Pharmaceu Biomed Anal. 2008;47(4–5):704–709.
   PubMed Web of Science ®Google Scholar
• Barbera L, Gattuso G, Kohnke FH, et al. Self-assembly of amphiphilic anionic calix [4] arenes and encapsulation of poorly soluble naproxen and flurbiprofen. Org Biomol Chem. 2015;13(23):6468–6473.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li H, Yang YW. Controlled drug delivery systems based on calixarenes. Chin Chem Lett. 2015;26(7):825–828.
   Web of Science ®Google Scholar
• Coleman AW, Jebors S, Cecillon S, et al. Toxicity and biodistribution of para-sulfonato-calix[4]arene in mice. New J Chem. 2008;32(5):780–782.
   Web of Science ®Google Scholar
• Tauran Y, Kumemura M, Tarhan MC, et al. Direct measurement of the mechanical properties of a chromatin analog and the epigenetic effects of para-sulphonato-calix[4]arene. Sci Rep. 2019;9(1):5816.
   PubMedGoogle Scholar
• Junejo R, Memon S, Memon FN, et al. Thermodynamic and kinetic studies for adsorption of reactive blue (RB-19) dye using calix[4]arene-based adsorbent. J Chem Eng Data. 2019;64(8):3407–3415.
   Web of Science ®Google Scholar
• Gutsche CD, Lin LG. Calixarenes 12: the synthesis of functionalized calixarenes. Tetrahedron. 1986;42(6):1633–1640.
   Web of Science ®Google Scholar
• Gutsche CD, Iqbal M, Stewart D. Calixarenes. 19. Syntheses procedures for p-tert-butylcalix [4] arene. J Org Chem. 1986;51(5):742–745.
   Web of Science ®Google Scholar
• Shinkai S, Araki K, Tsubaki T, et al. New syntheses of calixarene-p-sulphonates and p-nitrocalixarenes. J Chem Soc Perkin Trans. 1987;1:2297–2299.
   Google Scholar
• Khokhar TS, Memon S, Memon FN, et al. Complexation of Ibuprofen with modified calix[4]arene: a potential candidate for drug delivery application. Pak J Pharm Sci. 2017;30(3):783–788.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Erdemir S. Calixarene-based receptors for molecular recognition. Turk J Chem. 2013;37(4):558–585.
   Web of Science ®Google Scholar
• Dibama HM, Clarot I, Fontanay S, et al. Towards calixarene-based prodrugs: drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix [4] arene ester adduct. Bioorg Med Chem Lett. 2009;19(10):2679–2682.
   PubMed Web of Science ®Google Scholar
• Lakowicz JR. Plasmonics in biology and plasmon-controlled fluorescence. Plasmonics. 2006;1(1):5–33.
   PubMed Web of Science ®Google Scholar
• Chawla HM, Srinivas K. Calix (n) arene-quinone interactions: molecular recognition of 2, 6-naphthoquinone by 5, 11, 17,23,29,35-hexa-tert-butyl-37,38,39,40,41, 42-hexahydroxycalix (6) arene. Tetrahedron. 1995;51(9):2709–2718.
   Web of Science ®Google Scholar
• Memon NA, Memon AA, Memon FN, et al. Determination of antibiotic drugs by a newly developed HPLC column prepared from calix[4]arene bonded mesoporous silica. Chromatographia. 2018;81(10):1373–1380.
   Web of Science ®Google Scholar
• Venuti V, Cannavà C, Cristiano MC, et al. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity. Coll Sur B. 2014;115:22–28.
   PubMed Web of Science ®Google Scholar
• Harris DC. Quantitative chemical analysis. Sixth ed. New York, NY: W. H. Freeman; 2003.
   Google Scholar
• Waratchada S, Wasinee K, Peter W, et al. Enhanced stability of a naringenin/2,6-dimethyl β-cyclodextrin inclusion complex: molecular dynamics and free energy calculations based on MM- and QM-PBSA/GBSA. J Mol Grap Mod. 2014;50:10–15.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors A. Phase-solubility techniques. Adv Ana Chem Instr. 1965;4:117–212.
   Google Scholar
• Benesi HA, Hildebrand J. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J Am Chem Soc. 1949;71(8):2703–2707.
   Web of Science ®Google Scholar
• Guyton and hall textbook of medical physiology, 12th Edition Chapter 64 Secretory functions of the alimentary tract. Elsevier, 1998.
   Google Scholar
• Deshpande AA, Rhodes C, Danish M. Intravaginal drug delivery. Drug Dev Ind Pharm. 1992;18(11–12):1225–1279.
   Web of Science ®Google Scholar
• Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Disc Today. 2002;7(10):569–579.
   PubMed Web of Science ®Google Scholar